Biofusion Therapeutics Limited
Develops and manufactures pharmaceutical formulations for global markets, not yet operational.
2021 | Bangaluru, Karnataka (India) | Merged
Biofusion Therapeutics Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
- Paid Up Capital ₹ 0.50 M
- Company Age 4 Year, 2 Days
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 42.71 Cr
- Revenue Growth 40.67%
- Profit Growth 2670.46%
- Ebitda -71.61%
- Net Worth 2642.46%
- Total Assets -64.51%
About Biofusion Therapeutics
Biofusion Therapeutics Limited (BTL) is Amalgamated company established on 18 Mar 2021 with its office registered at Bangaluru, Karnataka, India and has been running since 4 Year, 2 Days with a paid up capital of 0.50 M. According to MCA records, 3 Directors are linked to this company as of 16 Jan 2025.
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U73100KA2021PLC145487
- Company No.
145487
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
18 Mar 2021
- Date of AGM
11 Aug 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Life Sciences
Biofusion Therapeutics Limited
Explore comprehensive data for Biofusion Therapeutics Limited, including financials, compliance details, shareholding patterns, and litigation history.
Who are the key members and board of directors at Biofusion Therapeutics?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kiran Shaw  | Director | 18-Mar-2021 | Current |
| Karaikal Krishnan | Director | 27-Jul-2022 | Current |
| Siddharth Mittal | Director | 18-Mar-2021 | Current |
Financial Performance of Biofusion Therapeutics.
Biofusion Therapeutics Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 40.67% increase. The company also saw a substantial improvement in profitability, with a 2670.46% increase in profit. The company's net worth Soared by an impressive increase of 2642.46%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Biofusion Therapeutics?
In 2023, Biofusion Therapeutics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Science Gallery BengaluruKiran Shaw is a mutual person
Mazumdar Shaw Medical FoundationKiran Shaw is a mutual person
Immuneel Therapeutics Private LimitedKiran Shaw is a mutual person
Trent LimitedKiran Shaw is a mutual person
Csep Research FoundationKiran Shaw is a mutual person
Biocon AcademySiddharth Mittal and Kiran Shaw are mutual person
Charges (Loans)
Open Charges
₹0
Satisfied Charges
₹427.14 M
Charges Breakdown by Lending Institutions
- Citi Bank N.A. : 42.71 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 21 Apr 2022 | Citi Bank N.A. | ₹42.71 Cr | Satisfied |
How Many Employees Work at Biofusion Therapeutics?
Biofusion Therapeutics has a workforce of 3 employees as of Mar 29, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Biofusion Therapeutics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Biofusion Therapeutics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Biofusion Therapeutics
Recent activity within the organization
- Annual General Meeting
Biofusion Therapeutics Limited last Annual general meeting of members was held on 11 Aug 2023 as per latest MCA records.
- Balance Sheet
Biofusion Therapeutics Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Bangalore.
- Charges
A charge registered on 21 Apr 2022 via Charge ID 100581935 with Citi Bank N.A. was fully satisfied on 26 Dec 2022.
- Director Appointment
Karaikal Narayanaswamy Murali Krishnan was appointed as a Director was appointed as a Director on 27 Jul 2022 & has been associated with this company since 2 years 7 months .
- Charges
A charge with Citi Bank N.A. amounted to Rs. 427.14 M with Charge ID 100581935 was registered on 21 Apr 2022.
- Director Appointment
Siddharth Mittal was appointed as a Director was appointed as a Director on 18 Mar 2021 & has been associated with this company since 4 years 2 days .
Frequently asked questions
What is the Incorporation or founding date of Biofusion Therapeutics Limited?
Biofusion Therapeutics Limited was incorporated on 18 Mar 2021.
What is authorized share capital and paid-up capital of Biofusion Therapeutics Limited?
The authorized share capital of Biofusion Therapeutics Limited is ₹ 1.50 M and paid-up capital is ₹ 0.50 M.
Who are the current board members & directors of Biofusion Therapeutics Limited?
Currently 3 directors are associated with Biofusion Therapeutics Limited.
- Karaikal Narayanaswamy Murali Krishnan
- Siddharth Mittal
- Kiran Mazumdar Shaw
What is the registered address of Biofusion Therapeutics Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Biofusion Therapeutics Limited is 4Th Floor Pod2 Brc Building Biocon Special Economic Zone, Bommasandra Industrial Ea India, Bengaluru, Karnataka, 560099.
What is the corporate identification number (CIN) and company number of Biofusion Therapeutics Limited?
The corporate identification number (CIN) of Biofusion Therapeutics Limited is U73100KA2021PLC145487 and the company number is 145487 as per Ministry of Corporate Affairs (MCA).
What has been the recent revenue trend for Biofusion Therapeutics Limited?
According to the financial reports for the fiscal year 2023, the revenue trend for Biofusion Therapeutics Limited has risen by 40.67%.
How many employees does Biofusion Therapeutics Limited currently have?
As Per 2023 financial reports, 3 employees are currently employed by Biofusion Therapeutics Limited.
What change has been observed in the net worth of Biofusion Therapeutics Limited, and by what percentage?
The financial reports for the fiscal year 2023 indicates that The net worth of Biofusion Therapeutics Limited has experienced an upsurge of 2642.46%.
When was the last Balance Sheet of Biofusion Therapeutics Limited filed with the ROC?
The most recent Balance Sheet for Biofusion Therapeutics Limited was filed with the ROC on 31 Mar 2023.
Unlock Business Insights – Explore Instantly!
Search company & director profiles for free and gain access to critical business data.
- 3.1M+ Companies
- 15M+ Legal Cases
- 525K+ Credit Ratings
- 5.8M+ Directors & KMP
- 750K+ Regulatory Alerts
- 1.1M+ Companies' Financial Records
People also Viewed
John ShawDirector